Search

Microalgae originating from wastewater has been exhibiting particularly promising results in terms of biohydrogen production and wastewater treatment. This paper aims to review the factors affecting production, pretreatment techniques to improve synthesis, advanced technologies utilized for enhancing biohydrogen production, and techno-economic feasibility evaluation of the processes at a commercial scale. Microalgae possess metabolic components to synthesize biohydrogen using photobiological and fermentative processes but must undergo pretreatment for efficient biohydrogen production. The efficiency of these processes is influenced by factors such as the microalgae species, light intensity, cell density, pH, temperature, substrates, and the type of bioreactors. Moreover, many limitations, such as oxygen sensitivity, altered thylakoid constitution, low photon conversion efficiency, light capture disruption, and the evolution of harmful by-products hinder the sustainability of biohydrogen production processes. High operational and maintenance costs serve as the major bottleneck in the scaling up of the process as an industrial technology. Therefore, future research needs to be directed towards increasing optimization of the processes by reducing energy and resource demand, recycling metabolic wastes and process components, genetically engineered microalgae to adopt more efficient routes, and conducting pilot studies for commercialization. • Wastewater-based microalgae is a potential source of biohydrogen. • Factors affecting the biohydrogen production from microalgal biomass are discussed. • Technologies related to biohydrogen production from microalgae are reviewed. • Key challenges of biohydrogen production process from microalgae are highlighted. [ABSTRACT FROM AUTHOR]

Bio-electrochemical systems, such as microbial fuel cells (MFCs), serve as greener alternatives to conventional fuel energy. Despite the burgeoning review works on MFCs, comprehensive discussions are lacking on MFC designs and applications. This review paper provides insights into MFC applications, substrates used in MFC and the various design, technological, and chemical factors affecting MFC performance. MFCs have demonstrated efficacy in wastewater treatment of at least 50% and up to 98%. MFCs have been reported to produce ∼30 W/m2 electricity and ∼1 m3/d of biohydrogen, depending on the design and feedstock. Electricity generation rates of up to 5.04 mW/m−2–3.6 mW/m−2, 75–513 mW/m−2, and 135.4 mW/m−2 have been found for SCMFCs, double chamber MFCs, and stacked MFCs with the highest being produced by the single/hybrid single-chamber type using microalgae. Hybrid MFCs may emerge as financially promising technologies worth investigating due to their low operational costs, integrating low-cost proton exchange membranes such as PVA-Nafion-borosilicate, and electrodes made of natural materials, carbon, metal, and ceramic. MFCs are mostly used in laboratories due to their low power output and the difficulties in assessing the economic feasibility of the technology. The MFCs can generate incomes of as much as $2,498.77 × 10−2/(W/m2) annually through wastewater treatment and energy generation alone. The field application of MFC technology is also narrow due to its microbiological, electrochemical, and technological limitations, exacerbated by the gap in knowledge between laboratory and commercial-scale applications. Further research into novel and economically feasible electrode and membrane materials, the improvement of electrogenicity of the microbes used, and the potential of hybrid MFCs will provide opportunities to launch MFCs from the laboratory to the commercial-scale as a bid to improve the global energy security in an eco-friendly way. [Display omitted] • MFCs, serve as greener alternatives to conventional fuel energy. • 30 days of MFC operation can yield up to 10.38 mA current and remove 94.3% of COD by bacterial strains. • MFCs are capable of generating ∼30 W/m2 of electricity and ∼1 m3/d of biohydrogen. • MFCs have a wastewater treatment efficacy of at least 50% and up to 98%. • MFC technology is narrow due to its microbiological, electrochemical, and technological limitations. [ABSTRACT FROM AUTHOR]